Medical Technology Analyst Zimmerman provides clinical feedback on Procept BioRobotics (PRCT) new Hydros Robotic System on an Analyst/Industry conference call to be held on September 5 at 3:30 pm.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRCT:
- Procept BioRobotics price target raised to $95 from $74 at Truist
- PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024
- Procept BioRobotics management to meet with Truist
- Procept BioRobotics price target raised to $94 from $80 at BofA
- Procept BioRobotics reaffirms FY24 revenue view $217M, consensus $216.69M
Questions or Comments about the article? Write to editor@tipranks.com